Created at Source Raw Value Validated value
June 24, 2022, 9 p.m. usa

Number of participants with adverse events, serious adverse event and infusion-related reactions as assessed by CTCAE v5.0;Safety evaluation- proportion of subjects undergoing DLT events

Number of participants with adverse events, serious adverse event and infusion-related reactions as assessed by CTCAE v5.0;Safety evaluation- proportion of subjects undergoing DLT events